Remarkably, DOT1L overexpression in the T‐47D and MCF‐7 cell lines significantly increased the proliferative capacity, migratory potential, and invasive capacity, which are phenotypic alterations that facilitate malignant progression, as observed in Cd‐exposed BC models (Figure S7, Supporting Information). Here, DOT1L is linked to breast cancer.